Hims IPO

forhims.com

Hims was founded in 2017 by Andrew Dudum and Jack Abraham. In an October 2020 press release, the company announced its plan to go public through a reverse merger with blank-check company Oaktree Acquisition Corp.

Hims is a telehealth service for men's wellness and care, providing treatment options for hair loss, ED & more. The company has raised nearly $200 million in Venture Capital funding from investors including DCM Ventures, Define Ventures, Material Companies, McKesson Ventures, Next Play Capital, NewView Capital, TriplePoint Venture Growth, Rx3 Ventures, 7 Global Capital, Maverick Ventures, IVP, Forerunner Ventures, and Thrive Capital. It has been widely reported that Hims last raised $100 million in February 2019 at a post-money valuation of $1 billion.

Founded2017
Total Funding to Date$197MM
Register for Details

For more details on financing and valuation for Hims, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Hims Ticker Symbol

Hims does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Hims Stock Price

The stock price for Hims will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Hims in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM